Effect of grade on disease-free survival and overall survival in FIGO stage I adenocarcinoma of the endometrium

Objective: To analyse the effect of differentiation on disease-free surviva l (DFS) and overall survival (OS) in patients with stage I adenocarcinoma o f the endometrium. Patients and methods: From 1979 to 1995, 350 patients wi th FIGO stage LA-IC with well (G1), moderately (G2) or poorly (G3) differen tiated tumors were treated with surgery and high dose-rate brachytherapy wi th or without external radiation. Median age was 65 years (39-86 years). Re sults: The 5-year DFS was 88+/-3% for the G1 tumors, 77+/-4% for the G2 tum ors, and 67+/-7% for the G3 tumors (P=0.0049). With regard to the events co ntributing to DFS, the 5-year cumulative percentage of local relapse was 4. 6% for the G1 tumors, 9.0% for the G2 tumors, and 4.6% (P=0.027) for the G3 tumors. Cumulative percentage of metastasis was 1.4, 6.3 and 7.2% (P<0.001 ), respectively, whereas percentages of death were 6.0, 7.9 and 20.7% (P<0. 001). The 5-year OS was 91+/-3, 83+/-4 and 76+/-7%, respectively (P=0.0018) . In terms of multivariate hazard ratios (HR), the relative differences bet ween the three differentiation groups correspond to an increase of 77% of t he risk of occurrence of either of the three events considered for the Dfs (HR=1.77, 95% Cl [0.94-3.33]), (P=0.078) for the G2 tumors and of 163% (HR= 2.63, 95% Cl [1.27-5.43]), (P=0.009) for the G3 tumors with respect to the G1 tumors. The estimated relative hazards for OS are, respectively, in line with those for DFS: HR=1.51 (P=0.282) for the G2 tumors; and HR=3.37 (P=0. 003) for the G3 tumors. Conclusion: Patients with grade 1 tumors are those least exposed to either local relapse, metastasis, or death. In contrast pa tients with grade 2 tumors seem to be at higher risk of metastasis, whereas patients with grade 3 tumors appear at higher risk of death. Since we have looked at the first of three competing events (local relapse, metastasis a nd death), this suggests that patients with grade 3 tumors probably progres s to death so fast that local relapse, if any, cannot be observed. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.